Takeda Pharmaceutical's Income from Non-Controlling Interests rose 123288.47% to $7.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $7.5 million, marking a year-over-year increase of 59381.52%. This contributed to the annual value of $5.9 million for FY2025, which is 55179.8% up from last year.
Takeda Pharmaceutical's Income from Non-Controlling Interests amounted to $7.5 million in Q4 2025, which was up 123288.47% from -$1.4 million recorded in Q3 2025.
Takeda Pharmaceutical's Income from Non-Controlling Interests' 5-year high stood at $7.5 million during Q4 2025, with a 5-year trough of -$1.4 million in Q3 2025.
Over the past 5 years, Takeda Pharmaceutical's median Income from Non-Controlling Interests value was $80266.1 (recorded in 2023), while the average stood at $286349.0.
Data for Takeda Pharmaceutical's Income from Non-Controlling Interests shows a peak YoY increase of 123288.47% (in 2025) and a maximum YoY decrease of 50473.67% (in 2025) over the last 5 years.
Takeda Pharmaceutical's Income from Non-Controlling Interests (Quarter) stood at $448660.1 in 2021, then crashed by 65.29% to $155723.0 in 2022, then plummeted by 48.46% to $80266.1 in 2023, then plummeted by 919.5% to -$657777.4 in 2024, then surged by 1232.88% to $7.5 million in 2025.
Its Income from Non-Controlling Interests was $7.5 million in Q4 2025, compared to -$1.4 million in Q3 2025 and -$691110.6 in Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value